|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Operating expenses: | |
| Research and development | |
| General and administrative | |
| Total operating expenses | |
| Loss from operations | |
| Other income (expense), net: | |
| Interest income | |
| Other income, net | |
| Total other income, net | |
| Net loss | |
| Other comprehensive (loss) income: | |
| Unrealized (loss) gain on available-for-sale investments | |
| Comprehensive loss | |
| Net loss per share - basic | |
| Net loss per share - diluted | |
| Weighted-average number of common shares outstanding - basic | |
| Weighted-average number of common shares outstanding - diluted |
Loading...
